EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Histopathological Features and Antiviral Efficacy in Patients Over 30 Years Old with Chronic Hepatitis B in the Indeterminate Phase

Ke-Ying Ou, Yue-Yang Ma, Chuan-Su Yuan, Yu-Jia Lu, Bin Liu, Jia-Nan Cui, Wei-Hao Zhao, Yong-Feng Yang, Qing-Fang Xiong

Turkish Journal of Gastroenterology · 2025

DOI: 10.5152/tjg.2025.25138 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Turkish Journal of Gastroenterology, 2025. Verfasst von Ke-Ying Ou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease and Liver Disease, the Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Jiangsu, Ch…. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Antiviral Agents. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims: There are still many controversies about whether antiviral therapy should be administered to patients with chronic hepatitis B (CHB) in the indeterminate phase. Thus, this study aimed to investigate the histopathological features and antiviral efficacy of HBeAg-negative CHB patients aged over 30 in the indeterminate phase. Materials and Methods: The clinical, laboratory, and histopathological characteristics of 666 CHB patients were assessed through a retrospective study. To identify factors associated with significant liver inflammation and fibrosis, inter-group differential analysis and binary logistic regression were conducted. Receiver operating characteristic curve analysis was used to determine the area under the curve and optimal cut-off values for relevant indicators. The antiviral efficacy was analyzed in 62 patients who received antiviral treat ment by inter-group differential analysis.

Results

A total of 70 patients were enrolled in the study. The median age was 40.5 years and 38 patients (54.28%) were male. Significant liver inflammation and significant liver fibrosis represented 30% and 55.7% of the patient cohort, respectively. Multivariate logistic regression analysis revealed that red blood cell count (RBC) and aspartate aminotransferase (AST) were independent predictors of sig nificant liver inflammation (odds ratio [OR] (95%CI): 0.34 (0.13,0.90), P = .03; OR (95%CI): 1.19 (1.05,1.34), P = .006). Aspartate amino transferase was also an independent predictor of significant liver fibrosis (OR (95%CI): 1.24 (1.06,1.47), P = .01). The negative conversion rate of hepatitis B virus (HBV) DNA was above 80% from 24 weeks after antiviral treatment, and low-level viremia (LLV) accounted for 6.5% (4/62) at 48 weeks after antiviral treatment.

Conclusion

Among HBeAg-negative CHB patients aged over 30 in the indeterminate phase, over half had significant liver inflamma tion or fibrosis. In addition, RBC was a protective factor for significant liver inflammation, and AST was a risk factor for significant liver inflammation and fibrosis in such patients. Notably, antiviral treatment was effective. However, long-term monitoring of HBV DNA and the occurrence of LLV and drug resistance should be conducted during treatment. Cite this article as: Ou K, Ma Y, Yuan C, et al. Histopathological Features and Antiviral Efficacy in Patients Over 30 Years Old with Chronic Hepatitis B in the Indeterminate Phase. Turk J Gastroenterol. Published online October 3, 2025. doi 10.5152/tjg.2025.25138.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B, ChronicAntiviral AgentsHumansMaleFemaleAdultRetrospective StudiesLiver CirrhosisMiddle AgedTreatment OutcomeLiverHepatitis B e AntigensAspartate AminotransferasesHepatitis B virusDNA, ViralROC CurveLogistic Models

Substanzen

Antiviral AgentsHepatitis B e AntigensAspartate AminotransferasesDNA, Viral

Autor:innen und Institutionen

  • Department of Infectious Disease and Liver Disease, the Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Jiangsu, China.
  • Clinical Research Center, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Jiangsu, China.

Zitieren

APA

Ou, K. Y., Ma, Y. Y., Yuan, C. S., Lu, Y. J., Liu, B., Cui, J. N., Zhao, W. H., Yang, Y. F., & Xiong, Q. F. (2025). Histopathological Features and Antiviral Efficacy in Patients Over 30 Years Old with Chronic Hepatitis B in the Indeterminate Phase. Turkish Journal of Gastroenterology. https://doi.org/10.5152/tjg.2025.25138

Vancouver

Ou KY, Ma YY, Yuan CS, Lu YJ, Liu B, Cui JN, et al. Histopathological Features and Antiviral Efficacy in Patients Over 30 Years Old with Chronic Hepatitis B in the Indeterminate Phase. Turkish Journal of Gastroenterology. 2025. doi:10.5152/tjg.2025.25138

BibTeX
@article{Ou2025,
  author = {Ou, Ke-Ying and Ma, Yue-Yang and Yuan, Chuan-Su and Lu, Yu-Jia and Liu, Bin and Cui, Jia-Nan and Zhao, Wei-Hao and Yang, Yong-Feng and Xiong, Qing-Fang},
  title = {Histopathological Features and Antiviral Efficacy in Patients Over 30 Years Old with Chronic Hepatitis B in the Indeterminate Phase},
  journal = {Turkish Journal of Gastroenterology},
  year = {2025},
  doi = {10.5152/tjg.2025.25138}
}
Kostenlos starten →